Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
04/2012
04/12/2012WO2012046047A1 Composition for use in the treatment of acne
04/12/2012WO2012046046A1 Composition for skin treatment
04/12/2012WO2012046009A1 Composition for intraocular implantation of bevacizumab
04/12/2012WO2012045994A1 Processes for preparing improved compositions
04/12/2012WO2012045863A1 Pharmaceutical compositions comprising glimepiride and polyethylene glycol castor oil
04/12/2012WO2012045859A1 A pharmaceutical composition comprising a thiazolidinedione
04/12/2012WO2012045809A1 Use of substituted methoxyalkoxyphenylalkyl derivatives as preservative, preserving method, compounds and composition
04/12/2012WO2012045801A1 Lactoferrin based complex coacervates and their uses
04/12/2012WO2012045282A1 Applications of arctigenin in formulating medicines for preventing or treating diseases related to red blood cell reduction
04/12/2012WO2012045198A1 Use of polysaccharides from radix isatidis in manufacture of medicaments against influenza virus
04/12/2012WO2012031382A4 Special nutrient supplements for pregnant women
04/12/2012WO2012017022A3 Pharmaceutical composition containing a serenoa repens extract
04/12/2012WO2012016845A3 Pharmaceutical formulation comprising a phosphodiesterase inhibitor
04/12/2012WO2012015998A3 Preservative free bimatoprost and timolol solutions
04/12/2012WO2012015996A3 Preservative free bimatoprost solutions
04/12/2012WO2012007906A3 Eudermic compositions
04/12/2012WO2012004691A3 Pharmaceutical formulations of rasagiline
04/12/2012WO2012003370A3 Functional vascularization with biocompatible polysaccharide-based hydrogels
04/12/2012WO2012003361A3 Nanoemulsion vaccines
04/12/2012WO2012002644A3 Sustained-release pharmaceutical composition containing pramipexole or pharmaceutically acceptable salt thereof with improved stability
04/12/2012WO2012002640A3 Transdermal drug delivery system containing donepezil
04/12/2012WO2012001705A3 Pharmaceutical compositions of (r)-lansoprazole
04/12/2012WO2012001093A3 Liquid formulations of rupatadine fumarate
04/12/2012WO2011163321A3 Composition and method of treating lipid encapsulated virus infections
04/12/2012WO2011160136A3 Progesterone containing oral dosage forms and related methods
04/12/2012WO2011159881A3 Il-10 and methods of treating ocular and other diseases
04/12/2012WO2011154442A3 Process for the preparation of o/w emulsions
04/12/2012WO2011137292A3 Injectable, load-bearing cell/microbead/calcium phosphate bone paste for bone tissue engineering
04/12/2012WO2011135581A3 Pharmaceutical compositions of dronedarone
04/12/2012WO2011132966A3 Transdermal absorption preparation
04/12/2012WO2011130246A3 Compositions with reactive ingredients, and wound dressings, apparatuses, and methods
04/12/2012WO2011128914A3 Extended release pharmaceutical compositions of pramipexole
04/12/2012WO2011127291A3 Compositions and methods for the treatment of a neoplasia
04/12/2012WO2011124953A3 Controlled release pharmaceutical compositions of tapentadol
04/12/2012WO2011119058A3 F3-peptide targeted lipid-based nanoparticles useful for the treatment of angiogenesis-dependent diseases
04/12/2012WO2011116139A3 Improved pharmaceutical compositions comprising cck- 8 and methods of delivery
04/12/2012WO2011106478A3 Apixaban formulations
04/12/2012WO2011102702A3 Process for the preparation of oral solid dosage forms comprising valsartan
04/12/2012WO2011084316A3 Formulations and methods for controlling mdi particle size delivery
04/12/2012WO2011083490A3 Stable veterinary composition for enhanced phosphorous uptake
04/12/2012WO2011080346A3 Pellets and microparticles of pravastatin sodium and a process of making them
04/12/2012WO2011077239A3 Slow release pharmaceutical compositions of iloperidone
04/12/2012WO2011064797A3 Controlled release pharmaceutical compositions of galantamine
04/12/2012WO2010141069A3 Pure peg-lipid conjugates
04/12/2012US20120089083 Apparatus for delivering foam
04/12/2012US20120088838 Methods for maintaining effective plasma concentrations of a pharmaceutical
04/12/2012US20120088821 Method for treating atherosclerosis or restenosis using microtubule stabilizing agent
04/12/2012US20120088778 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
04/12/2012US20120088739 Method for treating meibomian gland disease
04/12/2012US20120088725 5-cnac as oral delivery agent for parathyroid hormone fragments
04/12/2012US20120088659 Compositions and Methods for Delivery of Materials
04/12/2012US20120087986 Pharmaceutical formulations comprising desvenlafaxine
04/12/2012US20120087985 Small peptide sequences for stabilizing biomolecules
04/12/2012US20120087984 Stabilization of chemical compounds using nanoparticulate formulations
04/12/2012US20120087983 Orthopedic application of encapsulated stem cells
04/12/2012US20120087982 Extended release opioid abuse deterrent compositions and methods of making same
04/12/2012US20120087981 Skin Engaging Member Comprising Encapsulated Actives
04/12/2012US20120087980 Stimulation of neuroregeneration by flavonoid glycosides
04/12/2012US20120087979 Extended-release oral dosage forms for poorly soluble amine drugs
04/12/2012US20120087978 Dosage forms of apixaban
04/12/2012US20120087977 Aqueous carbonated medium containing an amino(meth)acrylate polymer or copolymer
04/12/2012US20120087976 Adjuvant compositions comprising a non-ionic isotonicity agent
04/12/2012US20120087975 Method of Producing A Cationic Liposomal Preparation Comprising A Lipophilic Compound
04/12/2012US20120087974 Increased effectiveness of allylamine drug compounds for topical treatment of fungal infections of the skin and skin appendages
04/12/2012US20120087973 siRNA MICROBICIDES FOR PREVENTING AND TREATING DISEASES
04/12/2012US20120087972 Winnie wipes
04/12/2012US20120087971 Contact drug delivery system
04/12/2012US20120087969 Mu-Conotoxin Peptides and Use Thereof as a Local Anesthetic
04/12/2012US20120087966 Antimicrobial foam
04/12/2012US20120087959 Nanodispersion of a drug and process for its preparation
04/12/2012US20120087958 Multi-Dimensional Biomaterial and Method for Producing the Same
04/12/2012US20120087957 Process for the preparation of pharmaceutical suspensions for inhalation
04/12/2012US20120087956 Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
04/12/2012US20120087955 Nanoparticulate megestrol formulations
04/12/2012US20120087954 Ion substituted calcium phosphate coatings
04/12/2012US20120087953 Pharmaceutical compositions of active pharmaceutical ingredient comprising sulphonylurea moiety with excellent dissolution properties
04/12/2012US20120087952 Pulmonary Delivery in Treating Disorders of the Central Nervous System
04/12/2012US20120087950 Functionalized calcium phosphate artificial bone and joint compositions and methods of use and manufacture
04/12/2012US20120087949 Oligonucleotide micelles
04/12/2012US20120087948 Particulate cartilage system
04/12/2012US20120087875 Buffered Gum Base For High PH Release
04/12/2012US20120087874 Warming compositions and delivery systems therefor
04/12/2012US20120087873 Urea Foam
04/12/2012US20120087872 Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
04/12/2012US20120087868 Nanoparticle-loaded cells
04/12/2012US20120085345 Nasal spray device
04/12/2012DE102010042338A1 Zusammensetzung zur Behandlung von Krebs mit kontrollierter Freisetzung des Wirkstoffes A composition for treatment of cancer with controlled release of the active ingredient
04/12/2012CA2813734A1 Use of rifalazil and analogues thereof to treat ocular disorders
04/12/2012CA2813696A1 Sour gelled emulsions
04/12/2012CA2813488A1 Composition for intraocular implantation of bevacizumab
04/12/2012CA2813146A1 Oral vaccine fast-dissolving dosage form using starch
04/12/2012CA2813003A1 Bortezomib formulations stabilised with boric acid
04/12/2012CA2811568A1 Novel composition
04/11/2012EP2438958A2 Methods of treating acne and rosacea with galvanic generated electricity
04/11/2012EP2438928A1 Emulsifying preparation
04/11/2012EP2438926A1 Vaccine for mycoplasma infection
04/11/2012EP2438922A1 Collagen production enhancer
04/11/2012EP2438917A1 Transdermal preparation
04/11/2012EP2438912A2 Plaster containing fentanyl
04/11/2012EP2438911A1 Pharmaceuticals compositions comprising sulphonylurea-class insulin secretagogue and polyethylene glycol castor oil
1 ... 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 ... 2991